▲ Peaking
Business
Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide
2sources
2articles
1velocity
+0%since first seen
just nowfirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (2)
- Retatrutide Helped Adults With Diabetes or Heart Disease Lose Up to 20 Percent of Their Weight, Study Finds Everyday Health · 1d ago
- Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide NewsNation · 1d ago
Related trends
▲ Peaking
Business
The Pete behind Jersey Mike’s was only 17 years old when he borrowed $125,000 to buy the chain—with some help from his high school football coach
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
▲ Peaking
Business
'The AI trade is still on': Wall Street sees Big Tech's spending as positive for semiconductor stocks
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
▲ Peaking
Business
Traders Are Getting a New Tool to Wager on the Biggest US Stocks
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
▲ Peaking
Business
A woman built a $400,000 ADU on her property so her parents can live rent-free
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
▲ Peaking
Business
Data centers are actually making your electric bill cheaper—but sinking AI demand could change that
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
▲ Peaking
Business